Inside India newsletter: India’s investment appeal dims as firms and funds pivot to the U.S.

India is facing weaker net FDI as foreign inflows of $90.8 billion on a trailing 12-month basis to January 2026 were offset by more than $50 billion of repatriation and $35.8 billion of overseas investment by Indian firms, leaving net FDI near an all-time low. Indian corporates are increasingly deploying capital to the U.S., where companies plan over $20 billion of investment, as AI, deep consumer markets, and manufacturing incentives pull global capital away from India. The trend is a negative read-through for India's investment outlook, rupee, and domestic capex cycle.

Analysis

The key second-order issue is not just slower foreign inflows, but a worsening capital recycling loop: when multinationals repatriate cash and Indian corporates deploy incremental capex offshore, India’s domestic multiplier weakens exactly when the market is relying on earnings growth to justify premium valuations. That creates a subtle but important drag on banks, industrials, and local capex beneficiaries because the expected private investment upcycle is being financed elsewhere rather than through domestic balance sheets.

The medium-term winner is the U.S. industrial/AI ecosystem, not just on direct capex but on supply-chain lock-in. Once Indian conglomerates anchor manufacturing and procurement in the U.S., vendor ecosystems, logistics routes, and technical standards tend to follow, reducing the probability that India captures the full value chain later. For India, the risk is that “global champion” firms become less India-centric over a 12–24 month horizon, which can cap domestic reinvestment and dilute the long-duration bullish case.

The currency angle is underappreciated: persistent outward investment plus profit extraction keeps pressure on the rupee even if headline FDI stays positive, so INR weakness can become self-reinforcing via imported inflation and tighter policy bias. That hurts domestic cyclicals more than exporters because the former face cost pressure without commensurate pricing power, while exporters get a translation tailwind and a natural hedge against capital flight.

Consensus may be overemphasizing India’s structural growth premium and underestimating how quickly sentiment can reprice when net FDI trends toward zero or negative. The catalyst window is months, not days: watch for further weak PMI/capex commentary, a softer rupee, and additional high-profile offshore deals, any of which could extend de-rating in rate-sensitive Indian equities. A reversal likely needs a clearer domestic reinvestment incentive regime or a sharp slowdown in U.S.-linked capex opportunities, neither of which is imminent.

Key Decisions for Investors

• Short India domestic cyclicals vs long India exporters: buy IT services or pharma exporters against a basket of Indian banks/industrials for a 3-6 month relative-value trade; thesis is persistent INR weakness and weaker domestic capex transmission.
• Add to U.S. industrial and semiconductor ecosystem beneficiaries on pullbacks over the next 1-2 months; use any India-related capital announcement as confirmation that cross-border capex is still flowing toward U.S. supply chains.
• Avoid chasing India broad-market beta here; if already long, trim 20-30% of exposure in rate-sensitive and capex-dependent names until net FDI and rupee trends stabilize.
• Consider an options hedge on INR via USD/INR calls or non-deliverable forwards for the next 3-6 months; risk/reward favors protection because capital outflow pressure can accelerate abruptly if sentiment turns.
• Relative long U.S. AI infrastructure proxies versus Indian tech-adjacent names for 6-12 months; the former have clearer monetization paths from global capex rotation, while Indian names face a slower domestic scale-up cycle.